Hybrid Event
20-22 May, 2025,
Steigenberger Wiltcher's, Brussels
20-22 May, 2025,
Steigenberger Wiltcher's, Brussels
Tuesday 20 May 2025
Authority Insights, Practical Commercial Guidance and Interactive Debate on Antitrust Challenges and Recent Developments for Patents & SPCs
Key Competition Law, SPC, and Patient Litigation Perspectives On:
Expert Insight from Antitrust Authorities
- Insight into authority approach and review of pharmaceutical merger control cases
- Be armed for negotiations on discriminatory pricing, discounts and rebates
- Analyse the legal fallout and changes needed in working practices from the Servier case
Practical Advice on Managing Antitrust Risk
- Examine commercial implications of merger control activity
- Avoid risk in information exchange between competitors
- Gain visibility on how FSR is operating and how it will affect your organisation
Prepare for Changes to Patents & SPCs and Discover How:
- EU-wide compulsory licensing instruments affect on your Regulatory Data Protection
- Impact of SPC revisions in the EU Pharma package on your business
- Update on how litigation is being affected by the Unified Patent Court (UPC)